SCHEMBL12830442

SCHEMBL12830442

O=C(CCc1ccccc1)Nc1csc(C2CCCCC2)c1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ RAB9A P51151 3/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ POLB P06746 5/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ KDM6B O15054 1/20 0.43
▸ KDM4D Q6B0I6 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ EGLN3 Q9H6Z9 1/20 0.43
▸ GAA P10253 3/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12830918 0.82 JAK2 (0.43) CYP2C19ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL12756856 0.81 ALDH1A1 (0.45) CYP2C19ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL7953300 0.80 ALDH1A1 (0.50) CYP2C19ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL27660770 0.75 RAB9A (0.54) CYP2C19ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL15480692 0.74 ALDH1A1 (0.46) ALDH1A1RAB9AKDM4EEPHX2EPHX1
SCHEMBL12756858 0.73 GHSR (0.43) ALDH1A1SMN1; SMN2HDAC2
SCHEMBL12756640 0.72 HCAR2 (0.59) RAB9ANPC1SMN1; SMN2KDM4ECYP2C9
SCHEMBL12756834 0.72 RAB9A (0.44) CYP2C19RAB9ANPC1SMN1; SMN2POLB
SCHEMBL1490241 0.71 ALOX15 (0.53) RAB9ANPC1SMN1; SMN2MAPTHTT
SCHEMBL1490571 0.71 HCAR2 (0.59) ALDH1A1RAB9ANPC1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CYP2C19 4629/4885ALDH1A1 4409/4885RAB9A 1174/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CYP2C19 4629/4885ALDH1A1 4409/4885RAB9A 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback